[Anemia of prematurity and treatment with recombinant human erythropoietin (rHuEPO): is there a benefit?].
Klosowski
S
S
Djebara
A
A
Bachiri
A
A
Haouari
N
N
Thelliez
P
P
Morisot
C
C
D000751:Anemia, Neonatal / Q000188:drug therapy*; D004921:Erythropoietin / Q000627:therapeutic use*; D005296:Ferrous Compounds / Q000627:therapeutic use; D005865:Gestational Age; D006801:Humans; D007231:Infant, Newborn; D011994:Recombinant Proteins; D016896:Treatment Outcome
D005296:Ferrous Compounds; D011994:Recombinant Proteins; D004921:Erythropoietin; C031621:ferrous fumarate